期刊文献+

COX-2和VEGF表达及其与胆管癌的相关性研究 被引量:2

Correlation of Between Expressions of COX-2 and VEGF in Cholangiocarcinama
下载PDF
导出
摘要 目的:探讨环氧合酶-2(COX-2)和血管内皮生长因子(VEGF)在胆管癌组织中的表达及其与胆管癌发生、发展及转移的关系。方法:运用免疫组织化学SP法研究COX-2和VEGF相关抗原在胆管癌组织中的表达。结果:43例胆管癌组织中COX-2和VEGF的表达阳性率分别为81.40%和76.74%,而二者在9例胆管结石病人的组织中均未见阳性表达;COX-2表达阳性率在胆管癌高、中分化组明显高于低分化组,转移阳性组明显高于转移阴性组,其差异均有显著性意义(P<0.05);VEGF的表达阳性率在胆管癌转移组明显高于未转移组,其差异有显著性意义(P<0.05);COX-2表达与VEGF表达呈正相关(r=0.727,P<0.01)。结论:COX-2和VEGF可能在胆管癌的发生、发展及转移过程中起着关键性作用,二者在血管生成过程中密切相关。 To investigate the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor(VEGF) in human cholangiocarcinoma and their correlation with clinicobiological behavior. Methods: Expressions of COX-2 and VEGF in 43 cases of human cholangiocarcinoma were detected with immunohistochemistry of SP. Resultsz Expression rates of COX-2 and VEGF in cholangiocarcinoma were 81.40% and 76.74%, respectively. No expression of COX-2 and VEGF in caculus of bile duct was detected. The positive rate of COX-2 was significantly higher in well-differentiated and moderately-differentiated or metastatic tumors than in poorly-differentiated or non-metastatic tumors. The positive rate of VEGF was significantly higher in metastatic tumors than in non-metastatic tumors. Conclusion: COX-2 and VEGF may play a crucial role in tumorigenesis, tumor progression and metastasis in cholangiocarcimoma and both may have close relation in the angiogenesis.
作者 郜朝霞 孙权
出处 《武汉大学学报(医学版)》 CAS 2006年第1期38-41,共4页 Medical Journal of Wuhan University
关键词 胆管癌 环氧合酶-2 血管内皮生长因子 免疫组织化学 Cholangiocarcinoma Cyclooxygenase-2 Vascular Endothelial Growth Factor Immunohistochemistry
  • 相关文献

参考文献12

  • 1Yoon JH, Canbay AE, Werneburg NW, et al. Oxysterols induce eyelooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis[J].Hepatology, 2004,39(3) :732.
  • 2Jian Huang Mei-Ying Cai Da-Peng Wei Immunology Department,West China University of Medical Sciences,Chengdu 610044,Sichuan Province,China.HLA class Ⅰ expression in primary hepatocellular carcinoma[J].World Journal of Gastroenterology,2002,8(4):654-657. 被引量:33
  • 3Akihiko TA, Yuichi NW, Kazuhiko K, et al. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction[J]. Oncology Reports, 2003, (10) : 339.
  • 4Kim HJ, Lee KT, Kim EK, et al. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis[J]. J Gastroenterol Hepatol, 2004,19(5) : 582.
  • 5Chariyalertsak S, Sirikulchayanonta V, Mayer D, et al. Aberrant cyclooxygenase isoxyme expression in human intrahepatic cholangiocarcinoma [J]. Gut, 2001,48(1) :80.
  • 6Wu GS, Wang JH, Liu ZR, et al. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcionoma[J]. Hepatobiliary Pancreat Dis Int, 2002, 1(3) :429.
  • 7Wu T, Han C, Lunz JG, et al. Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells[J].Hepatology, 2002,36(2) :363.
  • 8Han C, Leng J, Demetris AJ, et al. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21wafl/cipl and p27kipl and cell cycle arrest[J]. Cancer Res, 2004, 64(4) : 1 369.
  • 9陈汝福,邹声泉.肝门部胆管癌组织中VEGF和血管生成相关性的研究[J].齐鲁肿瘤杂志,1999,6(2):99-101. 被引量:4
  • 10Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by Colon cancer cells[J]. Cell, 1998, 93:705.

二级参考文献10

  • 1Paroli M,Carloni G,Franco A,De Petrillo G,Alfani E,Perrone A,Barnaba V.Human hepatoma cells expressing MHC antigens display accessory cell function,dependence on LFA-1/ICAM-1 interaction[].Immunology.1994
  • 2Ruiz-Cabello F,Garrido F.HLAand cancer:Fromresearch to clinical impact[].Immunology Today.1998
  • 3Sung CH,Hu CP,Hsu HC,Ng AK,Chou CK,Ting LP,Su TS,Han SH,Chang CM.Expression of class Ⅰ and class Ⅱ major histocompatibility antigens on human hepatocellular carcinoma[].The Journal of Clinical Investigation.1989
  • 4Wadee A A,Paterson A,Coplan KA,Reddy SG.HLA expression in hepatocellular carcinoma lines[].Clinical and Experimental Immunology.1994
  • 5Alexander,JJ,Bey,EM,Geddes,EW,Lecatsas,G.Establishment of a continuously growing cell line from primary carcinoma of the liver[].South African Medical Journal.1976
  • 6Aden,DP,Fogel,A,Plotkin,S,Damjanov,I,Knowles,BB.Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line[].Nature.1979
  • 7Jr,Vollmer,CM,Eilber,FC,Butterfield,LH,Ribas,A,Dissette,VB,Koh,A,Montejo,LD,Lee,MC,Andrews,KJ,McBride,WH,Glaspy,JA,Economou,JS.Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma[].Cancer Research.1999
  • 8Butterfield,LH,Koh,A,Meng,W,Vollmer,CM,Ribas,A,Dissette,V,Lee,E,Glaspy,JA,McBride,WH,Economou,JS.Generation of Human T-cell Responses to an HLA-A2.1-restricted peptide epitope derived from alpha-Fetoprotein[].Cancer Research.1999
  • 9Butterfield L,Meng W,Koh A,et al.T cell responses to HLA-A* 0201-restricted peptides derived from human alpha-fetoprotein[].J Immunol.2001
  • 10Paterson AC,Sciot R,Kew MC,Callea F,Dusheiko GM,Desmet VJ.HLA expression in human hepatocellular carcinoma[].British Journal of Cancer.1988

共引文献35

同被引文献59

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部